Genomics and neurodegenerationÂ… the endgame Free

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

x Mobile version: slides + audio only
-15s 00:00 / 35:06 +15s
Minimise video

John Hardy lectures on selective vulnerability in genomics. He explains how to identify genetic variants by risk allele frequency, and then talks specifically about the genetics of Parkinson’s and Alzheimer’s disease. 

This lecture was part of an event called ‘Key advances in neurodegenerative disorders’ at The Royal Society of Medicine in London. 

Date of lecture: 26th November 2014  

This video is available for iPad via Safari 

Length: 00:35:06

00:00:01 - Introduction
00:15:24 - Insights
00:28:42 - FTD and ALS
00:33:29 - Conclusion
00:00:01
00:01:22
00:07:49
00:09:10
00:09:40
00:10:25
00:12:09
00:13:15
00:13:23
00:14:20
00:15:11
00:15:24
00:18:45
00:19:01
00:19:11
00:20:40
00:21:07
00:23:32
00:24:29
00:25:00
00:25:08
00:27:05
00:27:34
00:28:42
00:28:55
00:30:05
00:30:30
00:30:38
00:30:52
00:31:45
00:31:54
00:32:00
00:32:15
00:33:39
25:30

Professor Adrian Hill, Chairman of the Centre for Clinical Vaccinology and Tropical Medicine at Oxford University. 

Free Archived View
34:32

David Jayne, Vasculitis Director, Addenbrooke's Hospital, Cambridge. 

CPD Archived View
22:27

David Stuart, Director of Structural Biology, Nuffield Department of Medicine, Oxford.

Free Archived View
43:35
CPD Archived View
30:09

Nick Reynolds, Chair of Research, British Association of Dermatologists. 

Free Archived View
24:23

Surinder Birring, Consultant Chest Physician, King's College Hospital NHS Trust. 

CPD View
18:19

Miles Standford, Consultant Ophthalmologist, St Thomas' Hospital. 

View
20:12

Rod Hay, Consultant Dermatologist, King's College Hospital NHS Foundation Trust. 

CPD View
38:47

Patrick Nee, Consultant, Critical Care & Emergency Medicine, St Helen's & Knowlsey Teaching Hospitals NHS Trust.

CPD View